4 transcripts
PRCT
Earnings call transcript
NASDAQ
2024 Q2
1 Aug 24
retention rates exceeding 90%. As a company, we benefit greatly from this high level of surgeon retention as our commercial team can focus on training new
PRCT
Earnings call transcript
NASDAQ
2024 Q1
1 May 24
. Additionally, our ability to maintain surgeon retention rates above 90% demonstrates the clear patient and surgeon benefits of our technology, which
PRCT
Earnings call transcript
NASDAQ
2023 Q4
27 Feb 24
benefits of our technology, which ultimately leads to increased utilization. As a company, we benefit greatly from this high level of surgeon retention
PRCT
Earnings call transcript
NASDAQ
2023 Q2
27 Jul 23
results. We are pleased to report a record quarter where our customers and patients continue to realize the significant clinical benefits Aquablation
- Prev
- 1
- Next